Skip to main content
Premium Trial:

Request an Annual Quote

ForteBio Hires Octet Distributors in Australia, New Zealand, and Switzerland

NEW YORK (GenomeWeb News) — ForteBio, a developer of label-free, real-time systems for biomolecular interaction analysis, this week said it has hired two distributors to sell its Octet instruments and related consumables in parts of Europe and the South Pacific.
 
Swiss company Bucher Biotec will exclusively distribute ForteBio’s products in that country, while Millennium Science, an Australian distributor, will sell the products in that nation and in neighboring New Zealand.
 
ForteBio CEO Winnie Wan said in a statement that the distribution deals “will accelerate our efforts to further penetrate and serve these key markets,” which have shown a “growing demand for label-free solutions that are flexible, cost-efficient and accurate.”
    
The company’s Octet tools are “designed to help accelerate the selection and characterization of therapeutic candidates by generating real-time kinetic and quantitative results quickly and easily,” ForteBio said in the statement.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.